David B. Masters
Geen lopende functies
Vermogen: 758 338 $ op 31-03-2024
Profiel
David B.
Masters was the founder of Gel-Del Technologies, Inc. founded in 1999, where he held the title of Chief Executive & Technology Officer until 2017.
In terms of former jobs, he worked as Director, Director-Science & Technology at PetVivo Holdings, Inc. from 2015 to 2022.
Dr. Masters received a doctorate degree from Rutgers University- Newark in 1992 and also holds undergraduate and graduate degrees from the same institution.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PETVIVO HOLDINGS INC
4.23% | 01-09-2023 | 708 727 ( 4.23% ) | 758 338 $ | 31-03-2024 |
Eerdere bekende functies van David B. Masters
Bedrijven | Functie | Einde |
---|---|---|
PETVIVO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01-10-2021 |
Gel-Del Technologies, Inc.
Gel-Del Technologies, Inc. Medical SpecialtiesHealth Technology Part of PetVivo Holdings, Inc., Gel-Del Technologies, Inc. manufactures thermoplastic biomaterial devices. The private company is based in St. Paul, MN. Masters. The company was founded by David B. Gel-Del Technologies was acquired by PetVivo Holdings, Inc. on April 10, 2015 for $17.22 million. | Chief Executive Officer | 01-12-2017 |
Opleiding van David B. Masters
Rutgers University- Newark | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PETVIVO HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Gel-Del Technologies, Inc.
Gel-Del Technologies, Inc. Medical SpecialtiesHealth Technology Part of PetVivo Holdings, Inc., Gel-Del Technologies, Inc. manufactures thermoplastic biomaterial devices. The private company is based in St. Paul, MN. Masters. The company was founded by David B. Gel-Del Technologies was acquired by PetVivo Holdings, Inc. on April 10, 2015 for $17.22 million. | Health Technology |